Yan Shen

2.1k total citations · 1 hit paper
40 papers, 1.1k citations indexed

About

Yan Shen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yan Shen has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Yan Shen's work include Cancer-related molecular mechanisms research (6 papers), Cervical Cancer and HPV Research (5 papers) and Nanoplatforms for cancer theranostics (3 papers). Yan Shen is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), Cervical Cancer and HPV Research (5 papers) and Nanoplatforms for cancer theranostics (3 papers). Yan Shen collaborates with scholars based in China, United States and Taiwan. Yan Shen's co-authors include Yueping Jin, Ying Wang, Chengcheng Yao, Shun Lü, Yongqiang Zhu, Liliang Xia, Hui Dong, Huajun Zheng, Yi Yang and Wenwen Zhang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Yan Shen

36 papers receiving 1.1k citations

Hit Papers

The Diversity of Gut Microbiome is Associated With Favora... 2019 2026 2021 2023 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan Shen China 17 589 382 294 167 147 40 1.1k
Guanhua Rao China 20 556 0.9× 351 0.9× 248 0.8× 73 0.4× 193 1.3× 34 1.1k
Akira Kitanaka Japan 23 751 1.3× 465 1.2× 165 0.6× 392 2.3× 92 0.6× 80 1.7k
Tiffany A. Coon United States 19 743 1.3× 174 0.5× 141 0.5× 242 1.4× 151 1.0× 27 1.1k
Tatsunori Suzuki Japan 17 373 0.6× 317 0.8× 215 0.7× 101 0.6× 117 0.8× 65 912
Shu Cheng China 19 510 0.9× 492 1.3× 170 0.6× 237 1.4× 71 0.5× 58 1.1k
Zhijun Ma China 20 726 1.2× 316 0.8× 375 1.3× 240 1.4× 95 0.6× 43 1.4k
Daniela Giunciuglio Italy 15 500 0.8× 261 0.7× 216 0.7× 226 1.4× 61 0.4× 18 1.0k
Chun‐Jung Ko Taiwan 18 356 0.6× 152 0.4× 156 0.5× 216 1.3× 105 0.7× 28 818
Rong Shi China 20 616 1.0× 268 0.7× 547 1.9× 74 0.4× 281 1.9× 63 1.2k
Wenjing Sun China 19 596 1.0× 209 0.5× 267 0.9× 233 1.4× 63 0.4× 72 1.1k

Countries citing papers authored by Yan Shen

Since Specialization
Citations

This map shows the geographic impact of Yan Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Shen more than expected).

Fields of papers citing papers by Yan Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Shen. The network helps show where Yan Shen may publish in the future.

Co-authorship network of co-authors of Yan Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Shen. A scholar is included among the top collaborators of Yan Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Shen. Yan Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ding, He, Mengmeng Long, Yuehuang Wu, et al.. (2025). Subcellular distribution of Prussian blue nanozymes dictates enzymatic activity and macrophage polarization for effective colitis therapy. Biomaterials. 325. 123622–123622.
2.
Qi, Xiaoyu, Yan Shen, Yiming Cao, et al.. (2025). HPV E6/E7‐Induced Acetylation of a Peptide Encoded by a Long Non‐Coding RNA Inhibits Ferroptosis to Promote the Malignancy of Cervical Cancer. Advanced Science. 12(10). e2414018–e2414018. 5 indexed citations
3.
Li, Yong, et al.. (2025). TRIM34 inhibits triple-negative breast cancer progression by attenuating fatty acid synthesis via facilitating FASN ubiquitination. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(7). 167958–167958.
4.
Meng, Hong, et al.. (2024). Accurate prenatal diagnosis of coarctation of the aorta by 3-step echocardiographic diagnostic protocol. BMC Pediatrics. 24(1). 552–552. 1 indexed citations
5.
Ding, He, Yuxin Zhang, Yu Mao, et al.. (2023). Modulation of macrophage polarization by iron-based nanoparticles. SHILAP Revista de lepidopterología. 3(2). 105–122. 22 indexed citations
6.
Sheng, Jingyi, Yang Liu, He Ding, et al.. (2023). Magnetic Delivery of Antigen‐Loaded Magnetic Liposomes for Active Lymph Node Targeting and Enhanced Anti‐Tumor Immunity. Advanced Healthcare Materials. 12(32). e2301232–e2301232. 12 indexed citations
7.
Shen, Yan, et al.. (2021). miR-141-5p Affects the Cell Proliferation and Apoptosis by Targeting BTG1 in Cervical Cancer. Cancer Biotherapy and Radiopharmaceuticals. 39(6). 395–405. 5 indexed citations
8.
Jin, Yueping, Hui Dong, Liliang Xia, et al.. (2019). The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti–Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC. Journal of Thoracic Oncology. 14(8). 1378–1389. 396 indexed citations breakdown →
9.
Yang, Fang, Yan Shen, Wenwen Zhang, et al.. (2018). An androgen receptor negatively induced long non-coding RNA ARNILA binding to miR-204 promotes the invasion and metastasis of triple-negative breast cancer. Cell Death and Differentiation. 25(12). 2209–2220. 101 indexed citations
10.
Shen, Yan, Fang Yang, Wenwen Zhang, et al.. (2017). The Androgen Receptor Promotes Cellular Proliferation by Suppression of G-Protein Coupled Estrogen Receptor Signaling in Triple-Negative Breast Cancer. Cellular Physiology and Biochemistry. 43(5). 2047–2061. 33 indexed citations
11.
Sun, Zijia, Yaqin Shi, Yan Shen, et al.. (2015). Analysis of different HER‐2 mutations in breast cancer progression and drug resistance. Journal of Cellular and Molecular Medicine. 19(12). 2691–2701. 41 indexed citations
12.
Fu, Ziyi, Chenbo Ji, Ping‐qing Gu, et al.. (2015). Systematic gene microarray analysis of the lncRNA expression profiles in human uterine cervix carcinoma. Biomedicine & Pharmacotherapy. 72. 83–90. 45 indexed citations
13.
Si, Yanna, et al.. (2012). Effects of dexmedetomidine pretreatment and postconditioning on renal ischemia-reperfusion injury in rats. Zhonghua mazuixue zazhi. 32(3). 301–303. 1 indexed citations
14.
Chen, Xiaojun, Sumin Wang, Li Liu, et al.. (2011). A Genetic Variant in the Promoter Region of Toll-Like Receptor 9 and Cervical Cancer Susceptibility. DNA and Cell Biology. 31(5). 766–771. 37 indexed citations
15.
Zhou, Junfang, Fen Huang, Xiuguo Hua, et al.. (2010). Inhibition of porcine transmissible gastroenteritis virus (TGEV) replication in mini-pigs by shRNA. Virus Research. 149(1). 51–55. 26 indexed citations
16.
Tian, Wenmin, et al.. (2010). Association between the Epidermal Growth Factor Gene and Intelligence in Major Depression Patients. Chinese Medical Sciences Journal. 25(2). 105–108. 1 indexed citations
17.
Xu, Lei, Jiansong Sheng, Zhongshu Tang, et al.. (2004). Cystatin C prevents degeneration of rat nigral dopaminergic neurons: in vitro and in vivo studies. Neurobiology of Disease. 18(1). 152–165. 49 indexed citations
19.
Xi, Yaguang, Keyue Ding, Yinghui Ren, Yan Shen, & Yang Ke. (2002). Esophageal cancer in Chinese population: no polymorphism in codon 149 of P21Waf1/Cip1 cyclin dependent kinase gene. Oncogene. 21(50). 7745–7748. 4 indexed citations
20.
Zhou, Jiawei, Yi Yu, Zhongshu Tang, Yan Shen, & Lei Xu. (2000). Differential expression of mRNAs of GDNF family in the striatum following 6-OHDA-induced lesion. Neuroreport. 11(14). 3289–3293. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026